Jiyan Biotech makes an appearance at the Annual Conference of Liver Disease New DrugsFrom December 13th to 14th, 2024, the 2024 Annual Meeting of the Liver Disease New Drug Alliance and the Symposium on Metabolic - Associated Fatty Liver Disease, co - hosted by the Liver Disease New Drug Alliance and YaoTimes, were successfully held in Shanghai. The event gathered over 30 liver disease experts and industry leaders from industry, academia, research, and investment. Centering on the theme "Seize the Opportunities of the Times and Conquer Stubborn Liver Diseases!", they delivered wonderful presentations.Metabolic - Associated Fatty Liver Disease（MAFLD）Fatty liver disease, or fatty liver for short, is marked by excessive fat accumulation and steatosis in hepatocytes. When a large quantity of fat is generated and cannot be promptly transported out of the liver, it accumulates in hepatocytes. Over time, fatty liver ensues.Metabolic - associated fatty liver disease (MAFLD) is the ...

In recent years, the biopharmaceutical industry has witnessed a diverse range of fortunes, with an overall sense of chill. After everyone has come to realize that the cold winter is unlikely to fade away on its own in the short term, it becomes particularly crucial to strive for ways to "break the situation."The 2024 Distrimap Scientific Research Tools Innovation and Development and Distribution Channel Conference and the Scientific Research Tools Industry Chain Exhibition successfully concluded in Shanghai on December 7th. Manufacturers of reagents, instruments, consumables, and innovative technologies in the biopharmaceutical industry, as well as channel distributors, engaged in comprehensive exchanges and dialogues. Jiyan Biotech was invited to participate and presented a sincere communication and report to distributors and industry peers. Jiyan Biotech's Keynote Speech: How to Be the First to "Seize the Opportunity"? At present, the sub - fields of organoids...

The 2024 Distrimap Scientific Research Tools Innovation, Development, and Distribution Channel Conference, along with the Scientific Research Tools Industry Chain Exhibition, will be held at the Crowne Plaza Shanghai Pujiang, Shanghai Construction Engineering on December 7th (this Saturday). Jiyan Biotech cordially invites you to attend. We will comprehensively showcase and introduce the high - quality products and services provided by Jiyan Biotech.Jiyan Biotech is dedicated to the construction of tumor organoid models and the development of organ - on - a - chip technology platforms. These are used for drug sensitivity testing, drug evaluation, potential target research, and the study of tumor disease mechanisms. It provides personalized and precise treatment strategies for patients and offers a novel in - vitro evaluation model for new drug discovery and development.We welcome new and existing customers, as well as agents, to visit Booth #C26!Come and learn about our products and se...

Jiyan Biotech has been granted a patent titled "A Bionic Intestinal Organ-on-a-Chip" (Authorization Announcement No. CN221720838U), with an application date of August 2024, which can rapidly cultivate a variety of bionic intestinal microstructures.The patent abstract reveals that this utility model pertains to a bionic intestinal organ - on - a - chip, comprising a chip body with a hydrogel chamber. The hydrogel chamber measures 0.5 - 3 cm in length, 0.5 - 3 cm in width, and 0.1 - 3 mm in height. It connects to a hydrogel inlet at one end and a hydrogel outlet at the other.Inside the chamber, a patterned 3D hydrogel scaffold is formed from photocurable hydrogel via a patterning mask. A cell seeding channel links to the chamber for cell inoculation into the 3D scaffold. Multiple fence - like microstructures on the chamber's sidewall connect it to two culture medium channels, each 0.5 - 4 cm long. This utility model enables rapid cultivation of diverse bionic intestinal mic...

New Product Release of Jiyan BiotechSpecialized Tissue Embedding Gel for Organoids (SE-Gel)Jiyan Biotech focuses on the field of precision oncology medical services, committed to the construction of tumor organoid models and the development of related chips. In scientific research, after the successful construction of organoids, it is necessary to conduct tissue morphology and specific marker identification. During this process, the technical challenges in embedding lie in embedding and sectioning. Traditional embedding methods that require high - temperature heating involve complex melting and solidification processes, with difficult - to - master time control, demanding constant attention. When using paraffin embedding, due to the small size of organoids, they are extremely likely to be lost, making it difficult to obtain satisfactory tissue sections, and it is hard to locate the target tissue after sectioning.To address the above pain points, Jiyan Biotech has launched SE - ...